DUBLIN--(BUSINESS WIRE)--The "Wearable Injectors Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global wearable injectors market is expected to grow from $6.24 billion in 2021 to $7.16 billion in 2022 at a compound annual growth rate (CAGR) of 14.8%. The market is expected to grow to $11.29 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%.
Major players in the wearable injectors market are Amgen, Becton, Dickinson, and Co, Enable Injections, Insulet Corporation, Ypsomed, Medtronic, Tandem Diabetes Care, Valeritas, and West Pharmaceutical Services.
The wearable injectors market consists of sales of wearable injectors and related services by entities (organizations, sole traders, and partnerships) that manufacture wearable injectors. Wearable injectors are drug delivery devices that adhere to the body while the drug is administered subcutaneously over a preset time duration. Only goods and services traded between entities or sold to end consumers are included.
The main types of wearable injectors are on-body injectors and off-body injectors. On-body injectors are drug delivery devices that are applied directly to the patient's skin, in the abdominal region or the back of the patient's arm. The various applications include immuno-oncology, diabetes, cardiovascular diseases, and others that are used by various end-users such as hospitals, clinics, and home care settings.
North America was the largest region in the wearable injectors market in 2021. Western Europe was the second-largest region in the wearable injectors market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2019, approximately 463 million adults were living with diabetes, and by 2045, it is estimated that around 700 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market.
The high cost associated with wearable injectors is expected to limit the growth of the wearable injectors market. According to Drug Development and Delivery, wearable injectors are single-use systems that are comfortably worn on the body that costs between $20 to $35 per unit, which is high. The high cost associated with wearable injectors has a negative impact on the wearable injectors market growth.
The focus areas for many companies in the wearable injectors manufacturing market have shifted to increasing mergers and acquisitions to acquire more production capabilities. Large prime manufacturers are forming joint ventures or buying small or midsized companies to acquire new capabilities or gain access to new markets.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
- Create regional and country strategies on the basis of local data and analysis
- Identify growth segments for investment
- Outperform competitors using forecast data and the drivers and trends shaping the market
- Understand customers based on the latest market research findings
- Benchmark performance against key competitors
- Utilize the relationships between key data sets for superior strategizing
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Key Topics Covered:
1. Executive Summary
2. Wearable Injectors Market Characteristics
3. Wearable Injectors Market Trends And Strategies
4. Impact Of COVID-19 On Wearable Injectors
5. Wearable Injectors Market Size And Growth
5.1. Global Wearable Injectors Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Wearable Injectors Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Wearable Injectors Market Segmentation
6.1. Global Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- On-Body Injectors
- Off-Body Injectors
6.2. Global Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Hospitals
- Clinics
- Homecare setting
6.3. Global Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Immuno-Oncology
- Diabetes
- Cardiovascular Diseases
- Other Applications
7. Wearable Injectors Market Regional And Country Analysis
7.1. Global Wearable Injectors Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Wearable Injectors Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Companies Mentioned
- Amgen
- Becton, Dickinson and Co.
- Enable Injections
- Insulet Corporation
- Ypsomed
- Medtronic
- Tandem Diabetes Care
- Valeritas
- West Pharmaceutical Services
- Sensile Medical AG
- Gerresheimer
- Dexcom
- Consort Medical
- United Therapeutics
- Buhler Motor GmbH
- Debiotech
- UNILIFE CORPORATION
- Cellnovo
For more information about this report visit https://www.researchandmarkets.com/r/8qq53p
